1. Home
  2. AMBO vs GLTO Comparison

AMBO vs GLTO Comparison

Compare AMBO & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBO
  • GLTO
  • Stock Information
  • Founded
  • AMBO 2000
  • GLTO 2011
  • Country
  • AMBO United States
  • GLTO Denmark
  • Employees
  • AMBO N/A
  • GLTO N/A
  • Industry
  • AMBO Other Consumer Services
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBO Real Estate
  • GLTO Health Care
  • Exchange
  • AMBO Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • AMBO 7.2M
  • GLTO 6.5M
  • IPO Year
  • AMBO 2010
  • GLTO 2020
  • Fundamental
  • Price
  • AMBO $2.64
  • GLTO $4.52
  • Analyst Decision
  • AMBO
  • GLTO Buy
  • Analyst Count
  • AMBO 0
  • GLTO 1
  • Target Price
  • AMBO N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • AMBO 127.9K
  • GLTO 17.6K
  • Earning Date
  • AMBO 12-30-2024
  • GLTO 03-07-2025
  • Dividend Yield
  • AMBO N/A
  • GLTO N/A
  • EPS Growth
  • AMBO N/A
  • GLTO N/A
  • EPS
  • AMBO N/A
  • GLTO N/A
  • Revenue
  • AMBO $7,839,000.00
  • GLTO N/A
  • Revenue This Year
  • AMBO N/A
  • GLTO N/A
  • Revenue Next Year
  • AMBO N/A
  • GLTO N/A
  • P/E Ratio
  • AMBO N/A
  • GLTO N/A
  • Revenue Growth
  • AMBO N/A
  • GLTO N/A
  • 52 Week Low
  • AMBO $1.00
  • GLTO $4.40
  • 52 Week High
  • AMBO $6.30
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • AMBO 56.53
  • GLTO 40.56
  • Support Level
  • AMBO $2.30
  • GLTO $4.50
  • Resistance Level
  • AMBO $2.90
  • GLTO $5.25
  • Average True Range (ATR)
  • AMBO 0.32
  • GLTO 0.34
  • MACD
  • AMBO 0.02
  • GLTO -0.05
  • Stochastic Oscillator
  • AMBO 79.00
  • GLTO 9.63

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: